Annual Scientific Meeting Abstract Update Abstract Update Abstract Update Abstract Update Abstract submissions are currently under review. Notifications will be emailed the week of April 21, 2025. Questions? Contact info@otopa.org View Meeting Website Questions? For questions about the Annual Scientific Meeting, please contact the PAO-HNS Meeting Manager, Jessica Winger: jwinger@pamedsoc.org or (717) 909-2693 .

Call for Abstracts Deadline Extended AGAIN! FINAL Deadline Tuesday, March 18 @ Midnight! Presentations may be Oral, Poser, or E-Poster format, which will be decided by the program committee after the abstract review. The 2025 meeting will feature sessions on Pediatric Otolaryngology, Facial Plastics, Know Your Clinical Practice Guidelines & Updates, Rhinology, Recruitment: Pearls and Pitfalls, Social Media in Medicine, in addition to the resident research session. Submissions with topics that provide practicing otolaryngologists with particularly novel research, techniques, and ideas that they can incorporate into their practices to improve patient outcomes, practice efficiency, or patient safety/quality improvement will be given first consideration for oral presentations in the general session; however, all topics will be evaluated and considered based on originality and scientific merit. All resident levels, as well as fellows and medical students are encouraged to submit. PAO-HNS will consider abstracts presented at other academic forums, and presentation at the 2025 meeting does not ordinarily preclude one's participation at other meetings. Cash prizes will be awarded for the top oral and poster presentations. Notifications will be emailed the week of April 21. Submit Today Questions? Contact PAO-HNS at info@otopa.org

Events Read the 2024 Meeting Wrap-Up View the 2024 Photo Gallery PAO-HNS PAO-HNS is a not-for-profit membership organization which represents and serves Otolaryngologists, Head and Neck Surgeons in Pennsylvania and the region. PAO-HNS is dedicated to the professional interests of otolaryngologists and their patients, promoting the highest professional and ethical standards of practice through education and advocacy. We're planning for 2025! Soundings Read the Winter 2024 PAO-HNS Newsletter!

Site Map Homepage About Officers Executive Council and Committees Annual Awards Staff Membership Join PAO-HNS Member Benefits Member Login Meetings and Events Annual Scientific Meeting Sponsors and Exhibitors Registration and Hotel Meeting Archive Advocacy For Patients Cosmetic and Reconstructive Ear Nose, Sinus, and Allergy Thyroid and Other Head & Neck Conditions Voice & Throat Disorders COVID-19 Search Site Map Terms of Use Privacy Policy

Member Benefits The following are the benefits you will receive as a member of PAO-HNS: Soundings Newsletter Members receive hard copies of Soundings, the PAO-HNS member newsletter. Legislative Representation Representation in the state legislature via our own lobbyist. Direct Input with Medicare Representation on the Novitas Solutions Carrier Advisory Committee (CAC), which has input into local Medicare reimbursement policy. Specialty Events Listings Members may post their specialty events at no cost. Priority Review for ENT Journals Priority review for possible publication in ENT Journal, the official journal of the PAO-HNS. National Representation Representation on the American Academy of Otolaryngology-Head Neck and Neck Surgery's Board of Governors. Discounted Registration for Annual Science Meeting Discounted registration to our annual Scientific Meeting featuring CME-approved educational seminars focused on current otolaryngology topics and family-oriented social functions. Join Now

Thyroid and Other Head and Neck Conditions In This Section: Obstructive Salivary Gland Disease Parathyroid Adenoma Parotid Gland (Salivary Glad) Tumors Obstructive Salivary Gland Disease Author(s): Nikolaus Hjelm, MD; David Cognetti, MD. Overview: Obstructive salivary gland disease occurs when there is an blockage in the outflow duct from the salivary gland that prevents saliva from traveling out of the gland and into a patient’s mouth. The backflow of saliva behind the blockage results in enlargement of the obstructed salivary gland. This is similar to a clogged sink drain. When a sink drain (the salivary duct) is clogged, the water backs up into the sink (the salivary gland) and overflows the sink (resulting in a swollen salivary gland). The most common cause of a salivary gland obstruction is a sialolith, also known as a salivary duct stone. Other frequent etiologies include mucus plugging and narrowing of the duct from scarring. The best way to treat obstructive salivary gland disease is to remove the blockage. In the past, treatment was limited to surgically removing the entire salivary gland. However, in the mid 1990s, sialendoscopy emerged in Europe as a gland preserving management option for diagnosing and removing salivary stones. Fortunately, there are several otolaryngologists in Pennsylvania who are experienced with sialendoscopy. Sialendoscopy is a minimally-invasive procedure in which your physician uses a very small camera scope to evaluate the ducts of the salivary glands. The scope passes through your mouth and into the natural entrance of the salivary duct and therefore does not require an incision or result in a scar. The camera ranges from 0.8 mm to 1.6 mm in size, and allows for visualization of the inside of the small salivary ducts. A working channel in the larger endoscopes allows for treatment of salivary stones and scarring with baskets, burrs, balloons, and lasers. The endoscope can also be used to irrigate the duct with saline or steroids to clear mucus plugs and alleviate inflammation. Symptoms: Most frequently include but are not limited to: Salivary gland swelling with eating Discomfort or pain in the salivary glands with eating Dry mouth Feeling of a hard and possibly tender mass in the mouth, on the face, or under the jaw What to Expect at Your Otolaryngologist Office Visit: Your otolaryngologist will ask you about your symptoms including but not limited to when you first noticed them, when they typically occur, how frequently they occur, and any exacerbating or alleviating factors. Careful examination by your physician will include a full head and neck examination to rule out other causes of your symptoms. The exam will include but is not limited to palpation of the affected area as well as palpation inside your mouth to localize the origin of your discomfort. Additional tests may include but are not limited to a CT scan or ultrasound of your head and neck. Treatment: If it is determined that sialendoscopy is indicated for assessment and treatment of your salivary problem, your otolaryngologist will schedule you for the procedure. This typically takes place in the operating room. The risks for this minimally invasive procedure are low as it simply involves looking within the duct. In patients with scarring or blockages in the duct, there is a small risk of damage to the duct. Most patients experience swelling of the salivary gland after the procedure. This is expected and subsides within the first few days. Massage of the gland helps with this, and it is important to stay well hydrated. In patients with a large salivary stone, your physician may need to make a small incision within the mouth to remove the stone. This heals very quickly and without scar (if you ever accidentally bit the inside of your cheek you know how quickly the mouth heals). In some rare cases when the stone is in the parotid gland (salivary gland on side of face) and is unable to be reached with the endoscope or an intraoral incision, a small skin incision in front of your ear may be required. After the procedure, you can resume a normal diet. If an incision was made, you should be careful brushing your teeth in that area. You doctor will likely recommend an oral rinse during the recovery period. Rarely, patients experience numbness along the side of their tongue, which typically improves with time. Occasionally, a stent is placed in the salivary duct at the time of the procedure. This stent is then removed at your postoperative visit after the duct is well healed. Parathyroid Adenoma Authors: Robert Saadi M.D., Elizabeth Cottrill M.D. Overview: The parathyroid glands are part of the body’s endocrine system and are located in the neck close to the thyroid gland. Most people have four glands, each roughly the size of a pea. These glands are responsible for making parathyroid hormone (PTH), a chemical which controls calcium levels in the blood by altering how it is absorbed in the gut, excreted in the kidney, and deposited in or released from the bones. Calcium is vital to the function of many different types of cells in the body, especially muscle and nerve cells. A parathyroid adenoma is a benign growth of one or more of the parathyroid glands which results in over production of PTH. Parathyroid adenomas account for the vast majority of what is called “primary hyperparathyroidism”. Primary hyperparathyroidism is about 3 times more common in women than in men and usually occurs in people in their 50’s and 60’s, but can occur at any age. While some genetic mutations are known, and tend to run in families (Multiple Endocrine Neoplasia or “MEN”), the majority of primary hyperparathyroidism is caused by sporadic mutations. There is no known cause, although radiation exposure to the neck may increase the risk. Most cases of primary hyperparathyroidism are due to over-growth of a single gland (about 80%). Less commonly, there is growth of multiple glands at once, termed parathyroid hyperplasia (about 20%). Less than 1% of cases are caused by a cancer (malignancy) of a parathyroid gland. In all of these cases, too much PTH causes the levels of calcium to rise in the blood. This results from more absorption of calcium from the gut, less excretion of calcium by the kidneys, and more calcium release from the bones. Symptoms: Many patients with primary hyperparathyroidism do not have any symptoms and, very often, it is diagnosed by routine blood work that incidentally finds a high calcium level. Symptoms that may be caused by elevated calcium in the blood include kidney stones, bone pain and weak bones, abdominal cramping, irritability or depression. When a cancer of the parathyroid gland is present, patients are more likely to have severe symptoms due to very high levels of hormone and, although rare, may also note hoarseness or a neck mass. What to Expect at Your Otolaryngologist Office Visit: Prior to seeing your otolaryngologist, you may have already been evaluated by your primary care doctor or an endocrinologist to rule out other diagnoses that are associated with high calcium levels. When the diagnosis of primary hyperparathyroidism is confirmed, additional tests may be necessary. Because parathyroid hormone causes calcium to be absorbed into the blood from bones, you may develop weak bones or osteoporosis which can be determined with a bone density test. If you have symptoms of kidney stones, radiographic imaging of your abdomen may sometimes be necessary. Depending on your medical and family history, your doctor may recommend genetic testing for MEN 1 or MEN2. Your Otolaryngologist will perform a head and neck examination at your visit. Parathyroid adenomas are generally not able to be felt in the neck, therefore, for surgical planning, your Otolaryngologist will often order certain imaging studies and may perform a bed-side ultrasound in clinic. An ultrasound of the neck, which may also be done by a radiologist, is an inexpensive and radiation-free method for looking for an enlarged gland. Sometimes, a Tc-sestimibi scan, which uses a drug that is taken up by a parathyroid adenoma and is then shown on imaging, will be required to locate the enlarged gland. A specialized CT or MRI scan may be necessary in some cases. Treatment: Treatment for primary hyperparathyroidism is often coordinated by a team of doctors including both an Endocrinologist and also an Otolaryngologist. The most common and effective treatment is to remove the enlarged gland or glands, with surgery. For patients who are not having obvious symptoms, there are criteria that help guide when to undergo surgery and when to observe. For patients who are not good candidates for surgery or who have severe kidney failure, a prescription medication may be given to lower the PTH levels. Surgery can be done with a minimally invasive approach through a very small incision in the neck when a parathyroid adenoma is clearly seen on imaging. Additional imaging may be performed the day of surgery to assist with this. If imaging does not localize the adenoma, a slightly larger incision is planned and all four glands are found and evaluated (“parathyroid exploration”). Removal of multiple over-active glands may be necessary to drop the parathyroid hormone to normal levels. Parathyroid hormone levels drop dramatically after removal of the adenoma and this is can be measured during the operation to confirm that all hyper-secreting glands have been removed. In some cases, the surgeon may have to switch from a minimally invasive approach to look at all four glands if levels do not drop appropriately or if visualization is difficult. Rarely, the location of the parathyroid glands will be abnormal and parathyroid glands may be found inside the thyroid gland, in the chest, or higher in the neck. The main risks of surgery include hoarseness, bleeding, and long-term low calcium levels. Hoarseness may result from stretch or damage to the nerve that controls the vocal cords. The risk of damage to this nerve is less than 4% for experiences surgeons. If bleeding occurs following surgery, it can result in a collection of blood in the neck, called a hematoma. Often these are small and resolve on their own over time, or they may require a procedure to drain the blood. Low calcium levels are actually expected for a short period after surgery since function of the normal glands is suppressed by the over-functioning gland, however long term low calcium is rare. Calcium and Vitamin D supplements may be needed after surgery for several weeks. Signs of low calcium include numbness and tingling around your lips and fingertips and in extreme cases muscular contractions called tetany. References 1. Cole DE, Webb S, Chan PC. Update on parathyroid hormone: new tests and new challenges for external quality assessment. Clin Biochem. 2007;40(9-10):585-90. 2. Mourad M, Buemi A, Darius T, Maiter D. Surgical options for primary hyperparathyroidism. Ann Endocrinol (Paris). 2015;76(5):638-42. Parotid Gland (Salivary Gland) Tumors Authors: Christopher Pool, MD (Penn State Hershey Medical Center) and Neerav Goyal, MD MPH (Penn State Hershey Medical Center) Overview: The parotid gland is a salivary gland located in front of the lower border of the ear. The nerve responsible for facial expression and movement, called the facial nerve, courses through the parotid gland. Tumors (or masses) of salivary glands occur most commonly in the parotid gland although they can occur less frequently in the sublingual (below the tongue) or submandibular gland (below the jaw).1, 2 The majority (75%) of parotid masses are benign (not cancerous) and a visit to your otolaryngologist-head and neck surgeon (ENT) will help determine the nature of the mass.3 Salivary gland tumors are rare, representing six to eight percent (6-8%) of head and neck tumors.1, 2 In the United States, there are approximately 2500 cases per year.1, 2 Although there are no predominant risk factors for salivary gland cancer, smoking has been associated with Warthin’s tumor, a type of non-cancerous salivary gland tumor.4, 5 Possible reasons for a parotid mass include: benign (non-cancerous) or malignant (cancerous) tumors, salivary cysts, salivary gland stones, sarcoid, autoimmune conditions, infections or other inflammatory processes. Many of these reasons present with a single-sided mass, but some conditions can be associated with a mass in both glands. Symptoms: Most patients with salivary gland tumors present with painless swelling of the parotid, submandibular (below the jaw), or sublingual (below the tongue) glands. Occasionally, the mass may be associated with facial droop as the facial nerve runs through the gland. Facial weakness or droop is more commonly found in cancerous masses. This droop may sometimes be recognized as a “Bell’s palsy.” Some patients may present with a lump in their neck or cheek. What to Expect at Your Otolaryngologist Office Visit: Your doctor will ask you questions to better understand when the swelling began, where it is located, and if you are in pain or discomfort. The physical exam will include an assessment of the mass or salivary glands as well as an assessment of your facial movement and facial function. Several additional tests may be helpful. Tissue diagnosis remains the gold standard for determining the nature of the mass.6 An ultrasound will be used to identify the architecture of the mass and a fine needle (FNA) will be used to collect a sample for pathologic analysis.7 This maybe done in the office by the otolaryngologist or by a radiologist or ultrasonographer at a separate visit. Some practices have someone (a cytopathologist or pathologist) review the slide immediately to ensure there are enough cells to help make the diagnosis. Your surgeon will also likely get a CT (“CAT”) scan or MRI to assess the extent of the parotid mass.9 Treatment: Surgery is the cornerstone of treatment of this disease, with most benign and low-grade cancers treated with surgery alone.10 Tumors that are high-grade, are treated more aggressively with radiation therapy in addition to surgery.11 Every effort is made to remove the entire tumor while preserving the facial nerve. In experienced hands and in patients with no evidence of facial nerve weakness, the risk to this nerve is usually low. Patients who have tumors that are non-cancerous or benign, can elect to have the masses followed instead of having surgery. However, many of these masses do continue to grow and get larger in size. The surgeon may recommend repeat imaging if you choose to follow the mass instead of surgery. The surgery is usually an outpatient surgery or associated with a short hospital stay. The surgeon may use a drain, or a small plastic tube, connected to a suction bulb to help keep the wound fluid out. The surgeon may also suggest a compressive dressing over the surgical wound. Your surgeon will be able to provide the most relevant information regarding your parotid tumor and how to best address it as well as more details regarding the surgery and associated risks. Further reading: Fine Needle Aspiration Salivary Gland Cancer References 1. Barnes L EJ, Reichart P, Sidransky D. (Eds). Pathology and Genetics of Head and Neck Tumours: Tumours of the Salivary Glands. World Health Organization.2005: 209. 2. Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L. Major and minor salivary gland tumors. Critical Reviews in Oncology/Hematology. 2010;74: 134-148. 3. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head and Neck Surgery. 1986;8: 177-184. 4. de Ru JA, Plantinga RF, Majoor MH, et al. Warthin's tumour and smoking. B-ent. 2005;1: 63-66. 5. Pinkston JA, Cole P. Cigarette smoking and Warthin's tumor. American Journal of Epidemiology. 1996;144: 183-187. 6. Liu CC, Jethwa AR, Khariwala SS, Johnson J, Shin JJ. Sensitivity, Specificity, and Posttest Probability of Parotid Fine-Needle Aspiration: A Systematic Review and Meta-analysis. Otolaryngology and Head and Neck Surgery. 2016;154: 9-23. 7. Christensen RK, Bjorndal K, Godballe C, Krogdahl A. Value of fine-needle aspiration biopsy of salivary gland lesions. Head and Neck. 2010;32: 104-108. 8. Maiorano E, Lo Muzio L, Favia G, Piattelli A. Warthin's tumour: a study of 78 cases with emphasis on bilaterality, multifocality and association with other malignancies. Oral Oncology. 2002;38: 35-40. 9. Lee YY, Wong KT, King AD, Ahuja AT. Imaging of salivary gland tumours. European Journal of Radiology. 2008;66: 419-436. 10. Lim YC, Lee SY, Kim K, et al. Conservative parotidectomy for the treatment of parotid cancers. Oral Oncology. 2005;41: 1021-1027. 11. Mahmood U, Koshy M, Goloubeva O, Suntharalingam M. Adjuvant radiation therapy for high-grade and/or locally advanced major salivary gland tumors. Archives of Otolaryngology - Head and Neck Surgery. 2011;137: 1025-1030.

Advocacy Update What We're Watching.... Noncompete Clauses/Restrictive Covenants On July 17, 2024 Governor Shapiro signed HB1633 into law. The measure, known as Act 74 of 2024 places, for the first time in PA statutory restrictions on noncompete agreements in physician employment contracts. Act 74 will limit noncompete agreements in physician contracts to maximum duration of one year. In a related matter, on August 20, 2024, a Federal District Court judge in Texas struck down the Federal noncompete rule. Senate Bill 25 A scope of practice measure that continues to be of interest to the physician community is SB25. This legislation is known as the Rural Certified Registered Nurse Practitioner Health Care Access Program. If passed into law, this program could be implemented in the 49 (our of 66) counties of the Commonwealth that are deemed rural. This bill will allow an eligible rural Certified Registered Nurse Practitioner to practice as an independent primary healthcare practitioner without a written or collaborative agreement with a physician. The bill requires a CRNP to comply with the requirements of law and standard of advanced nursing care and recognize limitations in knowledge and experience. A CRNP must wear a name identification badge showing the professional title and must inform patients of the title before or during the initial patient encounter. Any signage or advertisements must contain a CRNP’s professional title. A CRNP is required to plan for the management of situations beyond a CRNP’s expertise and consult with and refer patients to other health care providers as appropriate. Senate Bill 25 excludes a collaborating physician from having any legal responsibility for acts or omissions of a CRNP while practicing under the program when there is a written or collaborative agreement with the physician outside of the program. The bill specifically prohibits a CRNP from practicing under the Medical Practice Act of 1985 or the Osteopathic Medical Practice Act through the program. No physician-patient relationship is established when a CRNP consults with a physician or seeks clinical information or guidance. SB25 has been reported out of the Senate Consumer Protection and Professional Licensure Committee as well as the Senate Appropriations Committee. It currently is on the legislative calendar for full Senate consideration this fall. House Bill 1235 SB 1235, if passed, would authorize PA to join the Audiology and Speech Language Pathology Interstate Compact. Although 33 states have passed legislation to join the Compact as of this writing, PAO has taken the position of opposing the legislation as currently written. Reasons for opposing the legislation are as follows; Despite assurances to the contrary, the proposed Interstate Compact for Audiology and Speech-language Pathology attempts to overtake the established licensure process and create a compact that puts the protection of the public in their own hands by creating a Commission that can override state laws, “Unlike the medical licensure compact where a physician must already be licensed to practice in a state (voluntary expedited licensure), this compact attempts to create and dictate initial universal licensure for two very different professions without adequate quality standards. For example, an ASLP licensed in a state with lower standards of practice would be allowed to practice in a state with stronger practice standards. Telehealth: The current compact proposal would allow any compact member to practice telehealth in any other member’s state without documenting appropriate standards of care are being met. Exclusion of physician members: Physician members are appointed to the state ASLP licensing boards, but this is excluded in the Compact. This compact calls for an audiology or speech language pathology service provider to be in compliance with state practice laws outside of their home state yet, the compact negates states’ jurisdictional testing requirements. Oversight is missing from the compact including continuing education. On August 29, 2024 members of the PAO had a meeting with the prime sponsor of the bill to relay their concerns with the legislation. From this discussion we found out that the legislation would most likely not advance this fall and will be reintroduced next year when the new legislative session begins. During the next 3 months, PAO will work with House staff to see if common ground can be found resulting in possible amendments to the measure. 2025 General Assembly Session Dates STATE HOUSE OF REPRESENTATIVES tba STATE SENATE tba

Meeting Archive Congratulations to the 2024 winners: First Place Oral Presentation: Asthma and Comorbid Obstructive Sleep Apnea: Outcomes after Hypoglossal Nerve Stimulation Surgery David Goldrich, MD Penn State Hershey Second Place Oral Presentation: A Novel Proof-Of-Concept Study of Mixed Reality Technology for Ideal Placement of Bone-Anchored Hearing Devices for Application in Complex Patient Populations Kelly Daniels, MD UPMC First Place Poster: Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma Pablo Llerena, BS Thomas Jefferson University Hospital Second Place Poster: Free Flap Neurotization and Radial Forearm Free Flap Reconstruction Improves Functional Outcomes in Hemiglossectomy Defects Eric Wu, MD University of Pittsburgh Medical Center Resident Jeopardy Bowl Winner: Combined team from PCOM & Jefferson Congratulations to the 2023 winners: First Place Oral Presentation: Effects of hypoglossal nerve stimulation surgery on rhinologic quality of life - A cohort study Glen D’Souza, Jefferson Second Place Oral Presentation: Cost Effectiveness of Non-echo Planar Diffusion Weighted MRI in the Surveillance of Cholesteatoma Terral Patel, UPMC First Place Poster: The Use of Actigraphy to Assess Sleep Improvement After Parathyroidectomy Christopher Tseng, PSU Second Place Poster: Efficacy of Fibrin Sealants in Reducing Postoperative Complications in Facial Plastic Surgery Hanel Eberly, PSU Resident Jeopardy Bowl Winner: Combined team from AHN, PCOM, & Jefferson Congratulations to the following winners: First Place Oral Presentation: Endoscopic Versus Microscopic Ear Surgery for Management of Cholesteatoma: A Cost Effectiveness Analysis Lauren Gardiner, MD University of Pittsburgh Medical Center Second Place Oral Presentation: The Effects of Adjuvant Radiotherapy on Survival in Elderly Patients with Advanced Head & Neck Squamous Cell Carcinoma Joann Butkus, MD Thomas Jefferson University Hospital First Place Poster: Acoustic Neuroma: A Surveillance, Epidemilogy, and End Results (SEER) Analysis Thomas Haupt, MD Howard University Second Place Poster: Viral Integration and Genomic Instability in HPV-Transformed Tonsillar Keratinocytes Emily Milarchi, MD Pennsylvania State University Resident Jeopardy Bowl Winner: Geisinger Medical Center Congratulations to the following winners: First Place Oral Presentation: Validity of the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) in a Pediatric Population Kelly Daniels, MD UPMC Second Place Oral Presentation: Human Papilloma Virus Integration Strictly Correlates with Global Genome Instability in Head and Neck Cancer Max Hennessy, MD Penn State Health Third Place Oral Presentations: Survivorship, At What Cost? Understanding Financial Toxicity in Patients with Head and Neck Cancer: A Systematic Review Shivam Patel, MD Penn State Health Clinical and Immunological Profile of Patients with Immune-Related Adverse Effects Following Treatment with Immune Checkpoint Inhibitors Angela Alnemri, MD Thomas Jefferson University Hospital Resident Jeopardy Bowl Winner: UPMC Pittsburgh Congratulations to the following winners: First Place Poster: Implant Failure and Osteomyelitis in the Setting of Selective Serotonin Reuptake Inhibitor Usage: A Case Report & Review of the Literature Katie Melder, MD University of Pittsburgh Second Place Poster: Post treatment Surveillance in Sinonasal Malignancies Prachi Patel, MD Thomas Jefferson University Hospital First Place Oral Presentation: Multi-institutional study utilizing surgery + cesium-131 brachytherapy in recurrent head and neck cancer Adam Luginbuhl, MD Thomas Jefferson University Hospital Second Place Oral Presentation: Analysis of spatial relationships between CD8 and FoxP3 cells using digital imaging in head and neck squamous cell carcinoma Uche Nwagu, MD Thomas Jefferson University Hospital Second Place Oral Presentation: Clinical Implications of the Integration Status of HPV in Head and Neck Cancer Brandon LaBarge, MD Penn State Health Resident Quizzo winners: Will Kennedy, MD and Ravi Shah, MD from the University of Pennsylvania. Congratulations to the following winners: First Place Oral Presentation: A Computer-Learning Neural Network Algorithm for the Radiographic Assessment of Thyroid Nodules : A Pilot Study Kelly Daniels Sidney Kimmel Medical College at Thomas Jefferson University Second Place Oral Presentation: Assessment of cranial base repair techniques in a validated cadaveric CPAP model Chandala Chitguppi, MD Thomas Jefferson University Hospital First Place Poster: Innervation of the Cricothyroid Muscle by the Recurrent Laryngeal Nerve and Implications for Clinical Practice Thomas Kaffenberger, MD University of Pittsburgh Medical Center Second Place Poster: Impact of gender on upper airway stimulation outcomes Kelly Daniels Sidney Kimmel Medical College at Thomas Jefferson University Resident Jeopardy Bowl Winners: B. Swendseid, MD, M. Chaskes, MD and J. Goldfarb, MD from Thomas Jefferson University Hospital Congratulations to the following winners: First Place Oral Presentation: Defining the role of CD169 macrophages in lymph node metastasis Michael Topf, MD Lewis Katz School of Medicine at Temple University Second Place Oral Presentation: High-Level Disinfection of Otorhinolaryngology Clinical Instruments: An Evaluation of the Efficacy and Cost-effectiveness of Instrument Storage Jason Yu, MD University of Pennsylvania Second Place Oral Presentation: Identification of Causative Mutations in Two Unrelated Kindreds with Familial Nonmedullary Thyroid Cancer Using Next-Generation Sequencing Darrin Bann Penn State Health Milton S. Hershey Medical Center First Place Poster: Quality of Life Comparison of exenterated versus non-exenterated patients with sinonasal and craniofacial malignancies Alexander Graf, MD Thomas Jefferson University Hospital Second Place Poster: Perfusion Dynamics in Pedicled and Free Tissue Reconstruction: Infrared Thermography and Laser Fluorescence Video Angiography Tom Shokri, MD Penn State Health Milton S. Hershey Medical Center Resident Jeopardy Bowl Winners: UMPC & PCOM

COVID-19 Resources The Pennsylvania Academy of Otolaryngology - Head and Neck Surgery (PAO-HNS) is aware of our members concerns during this challenging time. Information on the coronavirus and COVID-19 continues to grow, which creates new recommendations that evolve and even change frequently. Many national organizations have created resources for physicians seeking guidance on the disease, its impact to our patients, the growing evidence of unique risks we face as surgeons, and the business challenges of practice operation during this time of limited patient visits and surgeries. In an effort to guide our colleagues in the state to helpful sources of information, we are providing these resources. The PAO-HNS hopes that as we remain dedicated to the care of our patients, we can likewise function in an educated and safe fashion to protect ourselves, our fellow healthcare workers, and our families. American Academy of Otolaryngology - Head and Neck Surgery Coronavirus 2019 Resources American College of Surgeons COVID-19 and Surgery Centers for Disease Control and Prevention Information for Healthcare Providers Pennsylvania Department of Health COVID-19 Information for Health Care Professionals Sub-Specialty Societies American Head and Neck Society COVID-19 Bulletin Board American Society of Pediatric Otolaryngology IPOD COVID-19 Survey Report American Rhinologic Society Coronavirus (COVID-19) Updates

PAO-HNS Abstracts 2024 Annual Scientific Meeting Each year the PAO-HNS invites practicing otolaryngologists to share their research, techniques, and ideas that they incorporate into their practices to improve patient outcomes, practice efficiency, or patient safety/quality improvement. All resident levels, including fellows and medical students are urged to submit. We are proud to share this year's top submissions. Thank you to all our participants!

Exhibitor & Sponsor Registration Support PAO-HNS at the Annual Scientific Meeting Exhibitor & Sponsor Registration is NOW OPEN! Click the image to the left to view the full prospectus. Support Opportunities $3,500 Exhibitor Package $2,500 SOLD Lanyard Sponsor Provide Lanyards for all attendees with company logo and PAO-HNS logo. $2,000 SOLD WIO Sponsorship One Hour Session with presentation from an esteemed female leader in the specialty of otolaryngology. $4,000 SOLD Logo on Hotel Key Card Have your company logo on the front of The Hotel Hershey key card. SOLD ISS Program | $7,000 Take advantage of the opportunity to present information about your product(s) one-on-one with program attendees by purchasing an Industry Sponsored Symposium (ISS). ISS programs are a separate, private function which do not compete with the PAO-HNS educational program or other events. You will have exclusive access to meeting attendees. Only paid exhibitors may purchase an ISS. Register Now User 2-Step Registration Process Our registration system has a two-step process. If you attended last year's meeting, use the same credentials to log in. If you are new, you will need to create a profile to register. STEP 1: Create profile/account. STEP 2: Register Register Now